HomeCompareCATM vs PFE

CATM vs PFE: Dividend Comparison 2026

CATM yields 5.13% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $23.1K in total portfolio value· pulled ahead in Year 9
10 years
CATM
CATM
● Live price
5.13%
Share price
$39.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$711.57
Full CATM calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — CATM vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCATMPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CATM + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CATM pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CATM
Annual income on $10K today (after 15% tax)
$435.79/yr
After 10yr DRIP, annual income (after tax)
$604.83/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $22,524.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CATM + PFE for your $10,000?

CATM: 50%PFE: 50%
100% PFE50/50100% CATM
Portfolio after 10yr
$39.5K
Annual income
$13,961.06/yr
Blended yield
35.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CATM
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CATM buys
0
PFE buys
0
No recent congressional trades found for CATM or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCATMPFE
Forward yield5.13%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$28.0K$51.1K
Annual income after 10y$711.57$27,210.54
Total dividends collected$6.2K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CATM vs PFE ($10,000, DRIP)

YearCATM PortfolioCATM Income/yrPFE PortfolioPFE Income/yrGap
1$11,213$512.69$9,161$701.38+$2.1KCATM
2$12,535$537.25$8,610$859.79+$3.9KCATM
3$13,974$561.31$8,366$1,081.25+$5.6KCATM
4$15,537$584.80$8,483$1,405.66+$7.1KCATM
5$17,232$607.68$9,084$1,907.24+$8.1KCATM
6$19,068$629.89$10,418$2,732.78+$8.7KCATM
7$21,054$651.41$13,007$4,193.56+$8.0KCATM
8$23,200$672.21$18,010$7,005.87+$5.2KCATM
9← crossover$25,516$692.27$28,216$12,979.89$2.7KPFE
10$28,014$711.57$51,081$27,210.54$23.1KPFE

CATM vs PFE: Complete Analysis 2026

CATMStock

Cardtronics plc provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. The company offers cash dispensing and balance inquiries; and financial related services to cardholders, as well as ATM management and ATM equipment-related services to large retail merchants, smaller retailers, financial institutions, and operators of facilities, such as shopping malls, airports, train stations, and casinos. It also provides transaction processing, cash and cash delivery management, supply, and telecommunications, as well as routine and technical maintenance services for ATMs; and owns and operates electronic funds transfer transaction processing platforms that offer transaction processing services to its network of ATMS, as well as other ATMs under managed services arrangements. In addition, the company provides processing services for issuers of debit cards; and owns and operates Allpoint network, a surcharge-free ATM network, which offers surcharge-free ATM access to participating banks, credit unions, digital banks, financial technology companies, and stored-value debit card issuers. As of April 1, 2020, it provided services to approximately 285,000 ATMs in North America, Europe, the Asia-Pacific, and Africa. The company was founded in 1989 and is based in Houston, Texas.

Full CATM Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CATM vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CATM vs SCHDCATM vs JEPICATM vs OCATM vs KOCATM vs MAINCATM vs JNJCATM vs MRKCATM vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.